Chemicals
Compare Stocks
2 / 10Stock Comparison
BAK vs AVNT
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
BAK vs AVNT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals | Chemicals - Specialty |
| Market Cap | $638M | $3.35B |
| Revenue (TTM) | $73.77B | $3.28B |
| Net Income (TTM) | $-5.24B | $158M |
| Gross Margin | 4.4% | 31.7% |
| Operating Margin | -2.8% | 9.3% |
| Forward P/E | — | 12.0x |
| Total Debt | $73.72B | $1.92B |
| Cash & Equiv. | $14.99B | $511M |
BAK vs AVNT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Braskem S.A. (BAK) | 100 | 35.9 | -64.1% |
| Avient Corporation (AVNT) | 100 | 147.3 | +47.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BAK vs AVNT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BAK is the clearest fit if your priority is growth exposure.
- Rev growth 9.7%, EPS growth -147.0%, 3Y rev CAGR -9.8%
- 9.7% revenue growth vs AVNT's 0.6%
AVNT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 14 yrs, beta 1.19, yield 2.9%
- 27.8% 10Y total return vs BAK's 1.7%
- Lower volatility, beta 1.19, Low D/E 80.6%, current ratio 1.66x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.7% revenue growth vs AVNT's 0.6% | |
| Quality / Margins | 4.8% margin vs BAK's -7.1% | |
| Stability / Safety | Beta 1.19 vs BAK's 1.95 | |
| Dividends | 2.9% yield, 14-year raise streak, vs BAK's 0.1% | |
| Momentum (1Y) | +4.1% vs BAK's +3.9% | |
| Efficiency (ROA) | 2.6% ROA vs BAK's -5.6%, ROIC 3.9% vs 1.5% |
BAK vs AVNT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BAK vs AVNT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AVNT leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BAK is the larger business by revenue, generating $73.8B annually — 22.5x AVNT's $3.3B. AVNT is the more profitable business, keeping 4.8% of every revenue dollar as net income compared to BAK's -7.1%. On growth, AVNT holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $73.8B | $3.3B |
| EBITDAEarnings before interest/tax | $2.7B | $445M |
| Net IncomeAfter-tax profit | -$5.2B | $158M |
| Free Cash FlowCash after capex | -$6.1B | $205M |
| Gross MarginGross profit ÷ Revenue | +4.4% | +31.7% |
| Operating MarginEBIT ÷ Revenue | -2.8% | +9.3% |
| Net MarginNet income ÷ Revenue | -7.1% | +4.8% |
| FCF MarginFCF ÷ Revenue | -8.2% | +6.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -18.7% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +95.6% | +3.8% |
Valuation Metrics
BAK leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
On an enterprise value basis, AVNT's 12.2x EV/EBITDA is more attractive than BAK's 13.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $638M | $3.3B |
| Enterprise ValueMkt cap + debt − cash | $12.5B | $4.8B |
| Trailing P/EPrice ÷ TTM EPS | -0.65x | 41.01x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.95x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 12.99x | 12.22x |
| Price / SalesMarket cap ÷ Revenue | 0.04x | 1.03x |
| Price / BookPrice ÷ Book value/share | — | 1.40x |
| Price / FCFMarket cap ÷ FCF | — | 17.16x |
Profitability & Efficiency
AVNT leads this category, winning 7 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), AVNT scores 5/9 vs BAK's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | +6.6% |
| ROA (TTM)Return on assets | -5.6% | +2.6% |
| ROICReturn on invested capital | +1.5% | +3.9% |
| ROCEReturn on capital employed | +1.4% | +4.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 |
| Debt / EquityFinancial leverage | — | 0.81x |
| Net DebtTotal debt minus cash | $58.7B | $1.4B |
| Cash & Equiv.Liquid assets | $15.0B | $511M |
| Total DebtShort + long-term debt | $73.7B | $1.9B |
| Interest CoverageEBIT ÷ Interest expense | -0.25x | 3.61x |
Total Returns (Dividends Reinvested)
AVNT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AVNT five years ago would be worth $7,726 today (with dividends reinvested), compared to $3,845 for BAK. Over the past 12 months, AVNT leads with a +4.1% total return vs BAK's +3.9%. The 3-year compound annual growth rate (CAGR) favors AVNT at 0.8% vs BAK's -28.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +26.7% | +16.0% |
| 1-Year ReturnPast 12 months | +3.9% | +4.1% |
| 3-Year ReturnCumulative with dividends | -63.3% | +2.3% |
| 5-Year ReturnCumulative with dividends | -61.5% | -22.7% |
| 10-Year ReturnCumulative with dividends | +1.7% | +27.8% |
| CAGR (3Y)Annualised 3-year return | -28.4% | +0.8% |
Risk & Volatility
AVNT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
AVNT is the less volatile stock with a 1.19 beta — it tends to amplify market swings less than BAK's 1.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AVNT currently trades 81.4% from its 52-week high vs BAK's 69.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.95x | 1.19x |
| 52-Week HighHighest price in past year | $5.29 | $44.85 |
| 52-Week LowLowest price in past year | $2.32 | $27.48 |
| % of 52W HighCurrent price vs 52-week peak | +69.9% | +81.4% |
| RSI (14)Momentum oscillator 0–100 | 53.9 | 55.2 |
| Avg Volume (50D)Average daily shares traded | 2.9M | 620K |
Analyst Outlook
AVNT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BAK as "Buy" and AVNT as "Buy". Consensus price targets imply 32.6% upside for AVNT (target: $48) vs -59.5% for BAK (target: $2). AVNT is the only dividend payer here at 2.95% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $1.50 | $48.40 |
| # AnalystsCovering analysts | 6 | 20 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +2.9% |
| Dividend StreakConsecutive years of raises | 0 | 14 |
| Dividend / ShareAnnual DPS | $0.02 | $1.08 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% |
AVNT leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BAK leads in 1 (Valuation Metrics).
BAK vs AVNT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is BAK or AVNT a better buy right now?
For growth investors, Braskem S.
A. (BAK) is the stronger pick with 9. 7% revenue growth year-over-year, versus 0. 6% for Avient Corporation (AVNT). Avient Corporation (AVNT) offers the better valuation at 41. 0x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate Braskem S. A. (BAK) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BAK or AVNT?
Over the past 5 years, Avient Corporation (AVNT) delivered a total return of -22.
7%, compared to -61. 5% for Braskem S. A. (BAK). Over 10 years, the gap is even starker: AVNT returned +27. 8% versus BAK's +1. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BAK or AVNT?
By beta (market sensitivity over 5 years), Avient Corporation (AVNT) is the lower-risk stock at 1.
19β versus Braskem S. A. 's 1. 95β — meaning BAK is approximately 63% more volatile than AVNT relative to the S&P 500.
04Which is growing faster — BAK or AVNT?
By revenue growth (latest reported year), Braskem S.
A. (BAK) is pulling ahead at 9. 7% versus 0. 6% for Avient Corporation (AVNT). On earnings-per-share growth, the picture is similar: Avient Corporation grew EPS -51. 6% year-over-year, compared to -147. 0% for Braskem S. A.. Over a 3-year CAGR, AVNT leads at -1. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BAK or AVNT?
Avient Corporation (AVNT) is the more profitable company, earning 2.
5% net margin versus -14. 6% for Braskem S. A. — meaning it keeps 2. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVNT leads at 6. 2% versus 1. 3% for BAK. At the gross margin level — before operating expenses — AVNT leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is BAK or AVNT more undervalued right now?
Analyst consensus price targets imply the most upside for AVNT: 32.
6% to $48. 40.
07Which pays a better dividend — BAK or AVNT?
In this comparison, AVNT (2.
9% yield) pays a dividend. BAK does not pay a meaningful dividend and should not be held primarily for income.
08Is BAK or AVNT better for a retirement portfolio?
For long-horizon retirement investors, Avient Corporation (AVNT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
19), 2. 9% yield). Braskem S. A. (BAK) carries a higher beta of 1. 95 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AVNT: +27. 8%, BAK: +1. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between BAK and AVNT?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
AVNT pays a dividend while BAK does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.